PRVA · Privia Health Group, Inc. · Documents

Jun 5

Current report 8-K

Regulation FD disclosure

May 29

Current report 8-K/A Events of May 22

Shareholder vote results

May 23

Current report 8-K Events of May 22

Charter or bylaw amendment, or fiscal year change, Shareholder vote results

May 9

Earnings call

Q1 2024 earnings call

May 9

Current report 8-K

Financial results

May 9

Quarterly report 10-Q FY2024 Q1, ended Mar 31

Quarterly report for FY2024 Q1

Revenue $415.24M ▲ 7.5% Net income $2.98M ▼ 59.3% Diluted EPS $0.02 ▼ 66.7%

Apr 4

Proxy statement DEF 14A Meeting May 22, 2024

Proxy statement

Apr 4

Annual report to holders ARS

Annual report to holders

Apr 4

Proxy statement DEFA14A

Proxy statement

Mar 22

Proxy statement PRE 14A Meeting May 22, 2024

Proxy statement

Feb 27

Earnings call

Q4 2023 earnings call

Feb 27

Current report 8-K

Financial results

Feb 27

Annual report 10-K FY2023, ended Dec 31

Annual report for FY2023

Revenue $1.66B ▲ 22.2% Net income $23.08M Diluted EPS $0.19

Jan 29

Current report 8-K Events of Jan 25

Director or officer change, or executive pay, Regulation FD disclosure

Jan 8

Current report 8-K

Regulation FD disclosure

Nov 21

Current report 8-K Events of Nov 16

Entered into a material agreement

Nov 3

Earnings call

Q3 2023 earnings call

Nov 3

Current report 8-K

Financial results

Nov 3

Quarterly report 10-Q FY2023 Q3, ended Sep 30

Quarterly report for FY2023 Q3

Revenue $417.28M ▲ 21.7% Net income $5.64M ▲ 247.5% Diluted EPS $0.05 ▲ 400.0%

Aug 3

Earnings call

Q2 2023 earnings call

Aug 3

Current report 8-K

Financial results

Aug 3

Quarterly report 10-Q FY2023 Q2, ended Jun 30

Quarterly report for FY2023 Q2

Revenue $413.35M ▲ 23.2% Net income $7.27M Diluted EPS $0.06

Jul 31

Current report 8-K

Director or officer change, or executive pay, Charter or bylaw amendment, or fiscal year change

Jun 29

Current report 8-K Events of Jun 23

Director or officer change, or executive pay

May 25

Current report 8-K Events of May 24

Shareholder vote results

May 10

Current report 8-K Events of May 9

Other events

May 10

Proxy statement DEFA14A

Proxy statement

May 8

Current report 8-K Events of May 4

Entered into a material agreement

May 4

Earnings call

Q1 2023 earnings call

May 4

Current report 8-K

Financial results

May 4

Quarterly report 10-Q FY2023 Q1, ended Mar 31

Quarterly report for FY2023 Q1

Revenue $386.28M ▲ 23.1% Net income $7.32M Diluted EPS $0.06

Apr 12

Current report 8-K Events of Apr 7

Director or officer change, or executive pay, Regulation FD disclosure

Apr 12

Proxy statement DEFA14A

Proxy statement

Apr 6

Proxy statement DEF 14A

Proxy statement

Apr 6

Annual report to holders ARS

Annual report to holders

Apr 6

Proxy statement DEFA14A

Proxy statement

Mar 21

Current report 8-K Events of Mar 16

Ended a material agreement, Other events

Mar 7

Current report 8-K Events of Mar 2

Unregistered sale of equity

Mar 1

Annual report 10-K FY2022, ended Dec 31

Annual report for FY2022

Revenue $1.36B ▲ 40.4% Net loss $8.59M Diluted EPS -$0.08

Feb 28

Earnings call

Q4 2022 earnings call

Feb 28

Current report 8-K

Financial results

Jan 9

Current report 8-K

Regulation FD disclosure

Nov 21

Current report 8-K Events of Nov 16

Entered into a material agreement

Nov 15

Current report 8-K Events of Nov 14

Director or officer change, or executive pay

Nov 15

Registration statement S-3ASR

Registration statement

Nov 10

Earnings call

Q3 2022 earnings call

Nov 10

Current report 8-K

Financial results

Nov 10

Current report 8-K Events of Nov 9

Charter or bylaw amendment, or fiscal year change

Nov 10

Quarterly report 10-Q FY2022 Q3, ended Sep 30

Quarterly report for FY2022 Q3

Revenue $342.9M ▲ 36.3% Net income $1.62M Diluted EPS $0.01

Aug 11

Earnings call

Q2 2022 earnings call